Tuberculosis Interferon Gamma Release Assay
- UID
- MFG/IVD/2020/000060_126091e08a4fa3cd7536f3f62f099f43_37e2a5eca4c82a180bc32e60121b0829
- Device class
- Class B
- Brand name
- EIA
- License holder
- Genomix Molecular Diagnostics Pvt Ltd
- Approving authority
- Telangana
- Product information
- For quantitative detection of Interferon Gamma (EIA) that respond to in-vitro stimulation by M. tuberculosis antigens in whole blood. It is intended for use as an aid in the diagnosis of tuberculosis (EIA) infection
Tuberculosis Interferon Gamma Release Assay is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000060_126091e08a4fa3cd7536f3f62f099f43_37e2a5eca4c82a180bc32e60121b0829. This device is marketed under the brand name EIA. The license holder is Genomix Molecular Diagnostics Pvt Ltd, and it is classified as Device Class Class B. The approving authority is Telangana.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.